Canopy Growth Corp.: Is This Stock Worth a Shot?

Canopy Growth Corp. (TSX:WEED) offers big potential long-term gains, but there are near-term risks.

| More on:

Marijuana stocks continue to attract significant investor attention, especially after the strong pullback since February.

Let’s take a look at Canopy Growth Corp. (TSX:WEED) to see if it deserves to be in your portfolio right now.

Focused growth

Canopy is doing all the right things as it consolidates its position as a market leader in the growing medical marijuana market and positions itself for the opening of a recreational market, potentially next year.

Management has made a series of key acquisitions, including the purchase of Mettrum Health, which provided a nice boost to the company’s list of registered medical marijuana patients, added new national brands, and brought important production facilities into the fold.

Production growth is a core part of Canopy’s strategy as it prepares for the opening of a Canadian recreational market pegged at a value of at least $5 billion per year.

In order to scale up quickly and do so in a cost-efficient way, Canopy has partnered with a real estate company, the Goldman Group. Under the agreement, Goldman will build or acquire properties and outfit them to meet Canopy’s production requirements.

Canopy will then lease the facilities from Goldman.

In addition, Canopy purchased the property that houses its head office as well as the surrounding land. The building has enough space to nearly triple production, and the 42 acres of land offers expansion opportunities.

On the sales side, the company just reported fiscal Q1 2018 revenue of $15.9 million, representing a 127% increase over the same period last year.

Canopy set up a new online sales platform this spring to provide patients with a single location to access all of the company’s brands as well as offer other producers an option to get their product to market.

International markets will be served by a new global brand that will initially focus on Germany and Chile.

Overall, the company is doing a great job as it solidifies its leadership position in the medical marijuana market.

What about the recreational market?

Canopy’s market capitalization at the time of writing is $1.55 billion, which is a lot for a company with quarterly revenue of $16 million and a net loss of $4.4 million.

So, investors are betting on the recreational market that is supposed to open next summer.

The Federal Government maintains its optimism that Canadians will be able to legally purchase marijuana by July 1 next year, but several provinces are already asking for Ottawa to extend the timeline.

At this point, I’d be careful betting on a summer 2018 launch.

The provinces are burdened with all of the difficult decisions, including setting prices, determining sales outlets, and figuring out how to oversee the market in their own backyards.

Given the significant political risks of a botched rollout, it wouldn’t be a surprise to see the whole thing get delayed for another year or two as the provinces try to get their ducks in order. As such, there is a risk that a significant pushback of the launch could hit marijuana stocks, including Canopy.

Should you buy now?

This company is poised to do well once the recreational market is finally up and running, and it could very quickly grow into its valuation.

If you think the recreation market will arrive on schedule, it might be worthwhile to start a position in Canopy, but I would keep the investment small right now.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Andrew Walker has no position in any stock mentioned.

More on Investing

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Is Rising But I’m Worried About This One Thing

Canopy Growth stock is soaring as the legalization effort makes real progress in both Germany and the United States.

Read more »

young woman celebrating a victory while working with mobile phone in the office
Investing

3 Roaring Stocks to Hold for the Next 20 Years

These top TSX stocks are excellent long-term buys, given their multi-year growth potential and solid underlying businesses.

Read more »

Two seniors float in a pool.
Dividend Stocks

TFSA: How to Earn $1,890 in Annual Tax-Free Income

Plunk these investments into your TFSA to earn passive income and avoid the taxman.

Read more »

grow dividends
Investing

Here’s My Top 3 TSX Stocks to Buy Right Now

Even though the TSX has been rising, there are still some good bargains out there. Here are three top compounding…

Read more »

Target. Stand out from the crowd
Investing

Prediction: This Canadian Growth Stock Could Double by 2030

Alimentation Couche-Tard (TSX:ATD) is a top growth stock that could do well over the next six or so years.

Read more »

Businessman holding AI cloud
Tech Stocks

Could Investing $20,000 in Nvidia Make You a Millionaire?

Nvidia stock has made investors millionaires in the last 10 years. Is it too late to invest to become a…

Read more »

Engineers walk through a facility.
Dividend Stocks

1 TSX Stock I Wouldn’t Touch With a 10-Foot Pole

AtkinsRéalis (TSX:ATRL) is one TSX stock I'd never invest in.

Read more »

money cash dividends
Stocks for Beginners

Have $500? 3 Absurdly Cheap Stocks Long-Term Investors Should Buy Right Now

If you're looking for cheap stocks, these three have a huge future ahead of them, all while costing far less…

Read more »